These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 28562350)
21. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer. Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854 [TBL] [Abstract][Full Text] [Related]
22. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells. Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440 [TBL] [Abstract][Full Text] [Related]
23. Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network. Shen A; Lin W; Chen Y; Liu L; Chen H; Zhuang Q; Lin J; Sferra TJ; Peng J Int J Oncol; 2015 Feb; 46(2):685-90. PubMed ID: 25422078 [TBL] [Abstract][Full Text] [Related]
24. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines. Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178 [TBL] [Abstract][Full Text] [Related]
25. P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells. Eun SY; Ko YS; Park SW; Chang KC; Kim HJ Oncol Rep; 2015 Jul; 34(1):195-202. PubMed ID: 26063340 [TBL] [Abstract][Full Text] [Related]
26. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition. Yu J; Han Q; Cui Y Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641 [TBL] [Abstract][Full Text] [Related]
27. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Law AY; Wong CK Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259 [TBL] [Abstract][Full Text] [Related]
28. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
29. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis. Kwak T; Drews-Elger K; Ergonul A; Miller PC; Braley A; Hwang GH; Zhao D; Besser A; Yamamoto Y; Yamamoto H; El-Ashry D; Slingerland JM; Lippman ME; Hudson BI Oncogene; 2017 Mar; 36(11):1559-1572. PubMed ID: 27669433 [TBL] [Abstract][Full Text] [Related]
30. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers. Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034 [TBL] [Abstract][Full Text] [Related]
31. U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis. Caruso A; Caselli E; Fiorentini S; Rotola A; Prandini A; Garrafa E; Saba E; Alessandri G; Cassai E; Di Luca D Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20446-51. PubMed ID: 19918067 [TBL] [Abstract][Full Text] [Related]
32. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer. Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394 [TBL] [Abstract][Full Text] [Related]
33. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway. Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629 [TBL] [Abstract][Full Text] [Related]
34. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
36. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition. Sun R; Qin C; Jiang B; Fang S; Pan X; Peng L; Liu Z; Li W; Li Y; Li G Mol Biosyst; 2016 Mar; 12(3):952-62. PubMed ID: 26798987 [TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532 [TBL] [Abstract][Full Text] [Related]
38. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway. Ping H; Guo L; Xi J; Wang D Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497 [TBL] [Abstract][Full Text] [Related]
39. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer. Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705 [TBL] [Abstract][Full Text] [Related]
40. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway. Lu J; Yang Y; Guo G; Liu Y; Zhang Z; Dong S; Nan Y; Zhao Z; Zhong Y; Huang Q Oncotarget; 2017 Jul; 8(30):49502-49514. PubMed ID: 28548934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]